Biomerica (BMRA) Free Cash Flow Growth (5y) (2015 - 2026)
Biomerica (BMRA) Free Cash Flow Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Biomerica | 5.57 Mn | 4.23 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 2.37% |
| Nov 30, 2025 | 5.36% |
| Aug 31, 2025 | 30.36% |
| May 31, 2025 | 28.35% |
| Feb 28, 2025 | -17.92% |
| Nov 30, 2024 | -16.92% |
| Aug 31, 2024 | -164.79% |
| May 31, 2024 | -1.03% |
| Feb 29, 2024 | -45.47% |
| Nov 30, 2023 | -26.73% |
| Aug 31, 2023 | -16.36% |
| May 31, 2023 | -20.56% |
| Feb 28, 2023 | -27.68% |
| Nov 30, 2022 | -35.42% |
| Aug 31, 2022 | -61.85% |
| May 31, 2022 | -66.58% |
| Feb 28, 2022 | 77.17% |
| Nov 30, 2021 | -65.09% |
| Aug 31, 2021 | 24.43% |
| May 31, 2021 | -96.62% |